Suppr超能文献

青光眼治疗临床试验中用于衡量视野缺损进展的评分系统。

Scoring systems for measuring progression of visual field loss in clinical trials of glaucoma treatment.

作者信息

Katz J

机构信息

Department of International Health, Johns Hopkins School of Hygiene and Public Health, Baltimore, Maryland 21205-2103, USA.

出版信息

Ophthalmology. 1999 Feb;106(2):391-5. doi: 10.1016/S0161-6420(99)90052-0.

Abstract

OBJECTIVES

To compare the statistical properties of two visual field scoring systems used by clinical trials of glaucoma treatments with a view to their performance as longitudinal measures of visual field progression.

DESIGN

Cohort study comparing the scoring systems used by the Advanced Glaucoma Intervention Study (AGIS) and the Collaborative Initial Glaucoma Treatment Study (CIGTS) using pairs of visual fields (C-30-2 of the Humphrey Analyzer) spaced 1 year apart.

PARTICIPANTS

Sixty-seven eyes of 56 subjects with glaucomatous visual field loss from a natural history study of glaucoma were examined.

METHODS

Because both scoring systems are scaled so that they range from 0 to 20, the AGIS and CIGTS scores were compared by scatterplot, Pearson correlation, and the mean difference between scores. The difference between pairs of scores 1 year apart was used to compare the temporal variability of each scoring system. The proportion of subjects whose visual field "deteriorated" in 1 year by the amount specified for unconfirmed progression in each clinical trial was calculated.

MAIN OUTCOME MEASURES

Mean difference in scores 1 year apart and the variance of these differences were measured.

RESULTS

The median scores for the first of the two fields was 5.2 (interquartile range [IQR] = 9.8) for CIGTS and 5.0 (IQR = 7.0) for AGIS. The CIGTS scores were slightly larger than AGIS scores by an average of 0.5 (P = 0.06). The mean CIGTS score of the baseline fields was 0.06 (standard deviation = 3.8) higher than the mean of the second fields and 0.12 (standard deviation = 2.8) higher for AGIS. Fifteen percent of eyes had CIGTS scores that deteriorated by three or more (the cutoff for unconfirmed progression) over 1 year, while 7.5% of eyes had AGIS scores that deteriorated by four or more (the AGIS cutoff for unconfirmed progression) over the same period. Twenty-one percent improved by CIGTS criteria, while 12% improved by AGIS criteria.

CONCLUSIONS

CIGTS scores are systematically slightly higher than AGIS scores. The CIGTS scoring system has higher temporal variability than the AGIS system. The CIGTS criterion for unconfirmed progression over a 1-year period is likely to lead to higher estimated rates of progression than the AGIS criteria. This is mostly because of the difference in the definition of progression between the two study criteria.

摘要

目的

比较青光眼治疗临床试验中使用的两种视野评分系统的统计特性,以评估其作为视野进展纵向测量指标的性能。

设计

队列研究,比较高级青光眼干预研究(AGIS)和协作初始青光眼治疗研究(CIGTS)使用的评分系统,使用间隔1年的成对视野(Humphrey分析仪的C-30-2)。

参与者

对来自青光眼自然史研究的56名患有青光眼性视野缺损的受试者的67只眼睛进行了检查。

方法

由于两种评分系统的范围均设定为0至20,因此通过散点图、Pearson相关性和评分之间的平均差异来比较AGIS和CIGTS评分。相隔1年的成对评分之间的差异用于比较每个评分系统的时间变异性。计算了在1年内视野按每项临床试验中未确认进展所规定的量“恶化”的受试者比例。

主要观察指标

测量相隔1年的评分的平均差异以及这些差异的方差。

结果

CIGTS的两个视野中第一个视野的中位数评分为5.2(四分位间距[IQR]=9.8),AGIS为5.0(IQR=7.0)。CIGTS评分略高于AGIS评分,平均高0.5(P=0.06)。基线视野的CIGTS平均评分为0.06(标准差=3.8),高于第二个视野的平均值,AGIS则高0.12(标准差=2.8)。15%的眼睛CIGTS评分在1年内恶化了三个或更多(未确认进展的临界值),而7.5%的眼睛AGIS评分在同一时期恶化了四个或更多(AGIS未确认进展的临界值)。按照CIGTS标准,21%的眼睛有所改善,按照AGIS标准,12%的眼睛有所改善。

结论

CIGTS评分系统性地略高于AGIS评分。CIGTS评分系统的时间变异性高于AGIS系统。CIGTS在1年内未确认进展的标准可能导致比AGIS标准更高的进展估计率。这主要是由于两项研究标准中进展定义的差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验